Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myasthenia Gravis | 22 | 2023 | 201 | 9.530 |
Why?
|
Peripheral Nervous System Diseases | 4 | 2020 | 700 | 1.700 |
Why?
|
Immunologic Factors | 6 | 2021 | 1575 | 1.370 |
Why?
|
Myositis | 4 | 2020 | 251 | 1.330 |
Why?
|
Muscular Diseases | 4 | 2020 | 557 | 1.260 |
Why?
|
Neurotoxicity Syndromes | 2 | 2020 | 290 | 1.040 |
Why?
|
Receptors, Cholinergic | 6 | 2022 | 238 | 1.010 |
Why?
|
Paraneoplastic Syndromes, Nervous System | 2 | 2024 | 23 | 0.980 |
Why?
|
Neuromuscular Diseases | 2 | 2020 | 253 | 0.950 |
Why?
|
Lambert-Eaton Myasthenic Syndrome | 2 | 2020 | 8 | 0.910 |
Why?
|
Myotonia Congenita | 1 | 2020 | 14 | 0.780 |
Why?
|
Myotonic Dystrophy | 1 | 2020 | 78 | 0.740 |
Why?
|
Immunoglobulins, Intravenous | 3 | 2022 | 657 | 0.720 |
Why?
|
Botulism | 1 | 2019 | 22 | 0.710 |
Why?
|
Histamine H1 Antagonists | 1 | 2019 | 100 | 0.690 |
Why?
|
Genes, cdc | 1 | 2019 | 116 | 0.680 |
Why?
|
Blepharoptosis | 1 | 2020 | 144 | 0.680 |
Why?
|
Ophthalmoplegia, Chronic Progressive External | 1 | 2018 | 17 | 0.670 |
Why?
|
Neural Conduction | 2 | 2020 | 468 | 0.620 |
Why?
|
Medical Order Entry Systems | 1 | 2023 | 544 | 0.600 |
Why?
|
Motor Neuron Disease | 1 | 2017 | 106 | 0.590 |
Why?
|
Immunotherapy | 5 | 2021 | 4414 | 0.580 |
Why?
|
Pregnancy Complications | 3 | 2017 | 2861 | 0.570 |
Why?
|
Myocarditis | 2 | 2022 | 770 | 0.520 |
Why?
|
Physical Examination | 1 | 2021 | 1239 | 0.510 |
Why?
|
Antibodies | 2 | 2020 | 2459 | 0.500 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2015 | 37 | 0.500 |
Why?
|
Desensitization, Immunologic | 1 | 2019 | 483 | 0.490 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2271 | 0.490 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3130 | 0.460 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3236 | 0.460 |
Why?
|
Decision Support Systems, Clinical | 1 | 2023 | 1162 | 0.460 |
Why?
|
Immunosuppressive Agents | 4 | 2020 | 4147 | 0.450 |
Why?
|
Disease Management | 3 | 2020 | 2450 | 0.420 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1199 | 0.400 |
Why?
|
Nervous System Diseases | 2 | 2021 | 1617 | 0.400 |
Why?
|
Peripheral Nerves | 1 | 2015 | 474 | 0.390 |
Why?
|
Patient Education as Topic | 1 | 2021 | 2275 | 0.390 |
Why?
|
Drug Hypersensitivity | 1 | 2019 | 883 | 0.380 |
Why?
|
Deglutition Disorders | 3 | 2020 | 604 | 0.360 |
Why?
|
Recovery of Function | 1 | 2018 | 2924 | 0.320 |
Why?
|
Autoantibodies | 3 | 2024 | 2036 | 0.300 |
Why?
|
Telemedicine | 2 | 2021 | 2853 | 0.290 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7276 | 0.290 |
Why?
|
Electromyography | 2 | 2020 | 1391 | 0.260 |
Why?
|
Physicians | 2 | 2021 | 4554 | 0.260 |
Why?
|
Pain | 1 | 2019 | 4961 | 0.240 |
Why?
|
Humans | 43 | 2024 | 742088 | 0.230 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2020 | 1659 | 0.220 |
Why?
|
Melanoma | 2 | 2020 | 5462 | 0.220 |
Why?
|
Neoplasms | 6 | 2024 | 21596 | 0.220 |
Why?
|
Paraneoplastic Syndromes | 1 | 2024 | 150 | 0.210 |
Why?
|
Self Administration | 2 | 2020 | 386 | 0.210 |
Why?
|
Skin Neoplasms | 2 | 2020 | 5662 | 0.210 |
Why?
|
Phenotype | 1 | 2019 | 16331 | 0.200 |
Why?
|
Diplopia | 1 | 2022 | 199 | 0.190 |
Why?
|
Infusions, Subcutaneous | 1 | 2020 | 42 | 0.190 |
Why?
|
Neuromuscular Junction Diseases | 2 | 2019 | 14 | 0.180 |
Why?
|
Complement C5 | 1 | 2020 | 111 | 0.180 |
Why?
|
Complement Inactivating Agents | 1 | 2020 | 50 | 0.180 |
Why?
|
Terfenadine | 1 | 2019 | 15 | 0.180 |
Why?
|
Electrodiagnosis | 1 | 2020 | 154 | 0.180 |
Why?
|
Pandemics | 4 | 2020 | 8328 | 0.180 |
Why?
|
Paresthesia | 1 | 2020 | 162 | 0.180 |
Why?
|
Thymus Neoplasms | 1 | 2022 | 268 | 0.180 |
Why?
|
Chloride Channels | 1 | 2020 | 225 | 0.170 |
Why?
|
Ice | 1 | 2020 | 104 | 0.170 |
Why?
|
Diphenhydramine | 1 | 2019 | 63 | 0.170 |
Why?
|
Prednisone | 2 | 2021 | 1567 | 0.170 |
Why?
|
Macrolides | 1 | 2020 | 201 | 0.170 |
Why?
|
Premedication | 1 | 2019 | 257 | 0.160 |
Why?
|
Guillain-Barre Syndrome | 1 | 2020 | 123 | 0.160 |
Why?
|
Chloroquine | 1 | 2020 | 280 | 0.160 |
Why?
|
House Calls | 1 | 2020 | 159 | 0.160 |
Why?
|
Urination Disorders | 1 | 2019 | 241 | 0.160 |
Why?
|
Pregnancy | 3 | 2017 | 29087 | 0.160 |
Why?
|
Polyneuropathies | 1 | 2019 | 139 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11472 | 0.160 |
Why?
|
Fasciitis | 1 | 2018 | 65 | 0.150 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2020 | 363 | 0.150 |
Why?
|
Plasma Exchange | 2 | 2020 | 155 | 0.150 |
Why?
|
Medication Errors | 1 | 2023 | 797 | 0.140 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 408 | 0.140 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 365 | 0.140 |
Why?
|
Female | 20 | 2021 | 379592 | 0.140 |
Why?
|
4-Aminopyridine | 1 | 2015 | 81 | 0.130 |
Why?
|
Encephalitis | 1 | 2019 | 423 | 0.130 |
Why?
|
Acetaminophen | 1 | 2019 | 544 | 0.130 |
Why?
|
Orphan Drug Production | 1 | 2015 | 50 | 0.130 |
Why?
|
Potassium Channel Blockers | 1 | 2015 | 171 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 851 | 0.120 |
Why?
|
Viral Vaccines | 1 | 2020 | 636 | 0.120 |
Why?
|
Registries | 2 | 2020 | 8077 | 0.120 |
Why?
|
Herpesvirus 4, Human | 1 | 2019 | 1040 | 0.120 |
Why?
|
Eosinophilia | 1 | 2018 | 531 | 0.120 |
Why?
|
Patients | 1 | 2020 | 892 | 0.120 |
Why?
|
Spinal Neoplasms | 1 | 2020 | 759 | 0.120 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1066 | 0.110 |
Why?
|
Aged | 12 | 2021 | 162944 | 0.110 |
Why?
|
Disease Progression | 2 | 2020 | 13256 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1123 | 0.110 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2414 | 0.110 |
Why?
|
Anti-Inflammatory Agents | 2 | 2019 | 1788 | 0.110 |
Why?
|
Immunologic Memory | 1 | 2019 | 1348 | 0.110 |
Why?
|
Male | 15 | 2021 | 349538 | 0.110 |
Why?
|
Consensus | 1 | 2021 | 2935 | 0.100 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1357 | 0.100 |
Why?
|
Neurology | 1 | 2020 | 762 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1899 | 0.100 |
Why?
|
Hydrocortisone | 1 | 2019 | 1825 | 0.100 |
Why?
|
Research | 1 | 2020 | 1999 | 0.100 |
Why?
|
Renal Dialysis | 1 | 2020 | 1780 | 0.090 |
Why?
|
Spinal Cord | 1 | 2019 | 1807 | 0.090 |
Why?
|
Adult | 9 | 2020 | 213712 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1847 | 0.090 |
Why?
|
Middle Aged | 13 | 2021 | 213127 | 0.090 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57683 | 0.090 |
Why?
|
Patient Care Team | 1 | 2021 | 2527 | 0.090 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15530 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3800 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2566 | 0.080 |
Why?
|
Th1 Cells | 1 | 2013 | 1056 | 0.080 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 1421 | 0.080 |
Why?
|
Kidney Diseases | 1 | 2019 | 2145 | 0.080 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5519 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2020 | 2978 | 0.080 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2536 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2130 | 0.070 |
Why?
|
Muscle, Skeletal | 2 | 2019 | 4933 | 0.070 |
Why?
|
Th17 Cells | 1 | 2013 | 765 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4379 | 0.070 |
Why?
|
Muscle Weakness | 2 | 2019 | 414 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2023 | 4440 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2021 | 77098 | 0.070 |
Why?
|
Ultrasonography | 2 | 2018 | 5978 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3239 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2022 | 62966 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5304 | 0.050 |
Why?
|
Internship and Residency | 1 | 2022 | 5774 | 0.050 |
Why?
|
Drug Resistance | 1 | 2017 | 1608 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2020 | 12017 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4438 | 0.050 |
Why?
|
Myoglobinuria | 1 | 2019 | 23 | 0.040 |
Why?
|
Adrenal Gland Diseases | 1 | 2020 | 138 | 0.040 |
Why?
|
Mastication | 1 | 2019 | 53 | 0.040 |
Why?
|
Urogenital Neoplasms | 1 | 2020 | 135 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7317 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2020 | 664 | 0.040 |
Why?
|
Rhabdomyolysis | 1 | 2019 | 150 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29010 | 0.040 |
Why?
|
Carotid Artery, Internal | 1 | 2019 | 445 | 0.040 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2020 | 299 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2020 | 659 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2018 | 1583 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1849 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 2019 | 1007 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12958 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35342 | 0.030 |
Why?
|
Eosinophils | 1 | 2018 | 953 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1780 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1440 | 0.030 |
Why?
|
Brain | 1 | 2019 | 26343 | 0.030 |
Why?
|
Vaccines | 1 | 2020 | 817 | 0.020 |
Why?
|
Hemolysis | 1 | 2012 | 420 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2495 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2013 | 1866 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2117 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8662 | 0.020 |
Why?
|
Cell Separation | 1 | 2013 | 1749 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8621 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2712 | 0.020 |
Why?
|
Anaphylaxis | 1 | 2012 | 746 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7901 | 0.010 |
Why?
|
Hypersensitivity | 1 | 2012 | 1093 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5975 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2013 | 4554 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10232 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 85649 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 56350 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10392 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40450 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20086 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13019 | 0.010 |
Why?
|
United States | 1 | 2022 | 69693 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72145 | 0.010 |
Why?
|
Concepts
(185)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(52)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_